Tidemark’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Tidemark's LLY Position: Q1 2026 in Review
Tidemark increased its Eli Lilly (LLY) stake by 38% in Q1 2026, buying an estimated $19.3K and bringing the position to 69 shares worth $63.5K. The position accounts for 0.02% of the portfolio, ranked #240.
Tidemark first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tidemark held 69 shares of Eli Lilly worth $63.5K as of Q1 2026.
- Tidemark bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
- Eli Lilly made up 0.02% of Tidemark's portfolio in Q1 2026, its #240 holding.
- Tidemark first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.